-
1
-
-
33749627330
-
Howtomodulate inflammatory cytokines in liver diseases
-
H. Tilg, A. Kaser, and A. R. Moschen, "Howtomodulate inflammatory cytokines in liver diseases," Liver International, vol. 26, no. 9, pp. 1029-1039, 2006.
-
(2006)
Liver International
, vol.26
, Issue.9
, pp. 1029-1039
-
-
Tilg, H.1
Kaser, A.2
Moschen, A.R.3
-
2
-
-
0029979369
-
Biologic basis for interleukin-1 in disease
-
C. A. Dinarello, "Biologic basis for interleukin-1 in disease," Blood, vol. 87, no. 6, pp. 2095-2147, 1996.
-
(1996)
Blood
, vol.87
, Issue.6
, pp. 2095-2147
-
-
Dinarello, C.A.1
-
3
-
-
42949163491
-
Mechanisms of hepatic fibrogenesis
-
S. L. Friedman, "Mechanisms of hepatic fibrogenesis," Gastroenterology, vol. 134, no. 6, pp. 1655-1669, 2008.
-
(2008)
Gastroenterology
, vol.134
, Issue.6
, pp. 1655-1669
-
-
Friedman, S.L.1
-
4
-
-
0024455086
-
Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor
-
K. Miyazawa, H. Tsubouchi, D. Naka et al., "Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor," Biochemical and Biophysical Research Communications, vol. 163, no. 2, pp. 967-973, 1989.
-
(1989)
Biochemical and Biophysical Research Communications
, vol.163
, Issue.2
, pp. 967-973
-
-
Miyazawa, K.1
Tsubouchi, H.2
Naka, D.3
-
5
-
-
0033040202
-
Reversing liver cirrhosis: Impact of gene therapy for liver cirrhosis
-
J. Fujimoto and Y. Kaneda, "Reversing liver cirrhosis: impact of gene therapy for liver cirrhosis," Gene Therapy, vol. 6, no. 3, pp. 305-306, 1999.
-
(1999)
Gene Therapy
, vol.6
, Issue.3
, pp. 305-306
-
-
Fujimoto, J.1
Kaneda, Y.2
-
6
-
-
0034815229
-
Hepatocyte growth factor in patients with three different stages of chronic liver disease including hepatocellular carcinoma, cirrhosis and chronic hepatitis: An immuno histochemical study
-
B. Bilezikçi, A. N. Haberal, and B. Demirhan, "Hepatocyte growth factor in patients with three different stages of chronic liver disease including hepatocellular carcinoma, cirrhosis and chronic hepatitis: an immuno histochemical study," Canadian Journal of Gastroenterology & Hepatology, vol. 15, no. 3, pp. 159-165, 2001.
-
(2001)
Canadian Journal of Gastroenterology & Hepatology
, vol.15
, Issue.3
, pp. 159-165
-
-
Bilezikçi, B.1
Haberal, A.N.2
Demirhan, B.3
-
7
-
-
0036196050
-
High serumhepatocyte growth factor levels in the acute stage of community-acquired infectious diseases
-
F. Nayeri, I. Nilsson, L. Brudin, A. Fryden, C. Söderström, and P. Forsberg, "High serumhepatocyte growth factor levels in the acute stage of community-acquired infectious diseases," Scandinavian Journal of Infectious Diseases, vol. 34, no. 2, pp. 127-130, 2002.
-
(2002)
Scandinavian Journal of Infectious Diseases
, vol.34
, Issue.2
, pp. 127-130
-
-
Nayeri, F.1
Nilsson, I.2
Brudin, L.3
Fryden, A.4
Söderström, C.5
Forsberg, P.6
-
8
-
-
0026448434
-
The importance of liver in the plasma clearance of hepatocyte growth factor (HGF) in rats
-
K. X. Liu, Y. Kato, M. Narukawa et al., "The importance of liver in the plasma clearance of hepatocyte growth factor (HGF) in rats," The American Journal of Physiology, vol. 263, no. 5, part 1, pp. 27-54, 1992.
-
(1992)
The American Journal of Physiology
, vol.263
, Issue.5
, pp. 27-54
-
-
Liu, K.X.1
Kato, Y.2
Narukawa, M.3
-
9
-
-
0028795170
-
Serum hepatocyte growth factor levels in liver diseases: Clinical implications
-
G. Shiota, J.-I. Okano, H. Kawasaki, T. Kawamoto, and T. Nakamura, Serum hepatocyte growth factor levels in liver diseases: clinical implications," Hepatology, vol. 21, no. 1, pp. 106-112, 1995.
-
(1995)
Hepatology
, vol.21
, Issue.1
, pp. 106-112
-
-
Shiota, G.1
Okano, J.-I.2
Kawasaki, H.3
Kawamoto, T.4
Nakamura, T.5
-
10
-
-
77957948638
-
Hepatocyte growth factor and chronic hepatitis C
-
E. Marín-Serrano, C. Rodríguez-Ramos, F. Díaz-García, L. Martín-Herrera, C. Fernández-Gutiérrezdel-Álamo, and J. A. Girón-González, "Hepatocyte growth factor and chronic hepatitis C," Revista Espanola de Enfermedades Digestivas, vol. 102, no. 6, pp. 365-371, 2010.
-
(2010)
Revista Espanola de Enfermedades Digestivas
, vol.102
, Issue.6
, pp. 365-371
-
-
Marín-Serrano, E.1
Rodríguez-Ramos, C.2
Díaz-García, F.3
Martín-Herrera, L.4
Fernández-Gutiérrezdel-Álamo, C.5
Girón-González, J.A.6
-
11
-
-
0038555371
-
Hepatocyte growth factor activates endothelial pro angiogenic mechanisms relevant in chronic hepatitis C-associated neo angiogenesis
-
J. Medina, L. Caveda, P. Sanz-Cameno et al., "Hepatocyte growth factor activates endothelial pro angiogenic mechanisms relevant in chronic hepatitis C-associated neo angiogenesis," Journal of Hepatology, vol. 38, no. 5, pp. 660-667, 2003.
-
(2003)
Journal of Hepatology
, vol.38
, Issue.5
, pp. 660-667
-
-
Medina, J.1
Caveda, L.2
Sanz-Cameno, P.3
-
12
-
-
0037103090
-
Serum concentrations of human hepatocyte growth factor is a useful indicator for predicting the occurrence of hepatocellular carcinomas in C-viral chronic liver diseases
-
H. Yamagamim, M. Moriyama, H. Matsumura et al., "Serum concentrations of human hepatocyte growth factor is a useful indicator for predicting the occurrence of hepatocellular carcinomas in C-viral chronic liver diseases," Cancer, vol. 95, no. 4, pp. 824-834, 2002.
-
(2002)
Cancer
, vol.95
, Issue.4
, pp. 824-834
-
-
Yamagamim, H.1
Moriyama, M.2
Matsumura, H.3
-
13
-
-
0037335527
-
Hepatocyte growth factor, transforming growth factor α, and their receptors as combined markers of prognosis in hepatocellular carcinoma
-
M. Daveau, M. Scotte, A. François et al., "Hepatocyte growth factor, transforming growth factor α, and their receptors as combined markers of prognosis in hepatocellular carcinoma," Molecular Carcinogenesis, vol. 36, no. 3, pp. 130-141, 2003.
-
(2003)
Molecular Carcinogenesis
, vol.36
, Issue.3
, pp. 130-141
-
-
Daveau, M.1
Scotte, M.2
François, A.3
-
14
-
-
0036189967
-
Polymorphonuclear neutrophils are a source of hepatocyte growth factor in patients with severe alcoholic hepatitis
-
J. Taïeb, C. Delarche, V. Paradis et al., "Polymorphonuclear neutrophils are a source of hepatocyte growth factor in patients with severe alcoholic hepatitis," Journal of Hepatology, vol. 36, no. 3, pp. 342-348, 2002.
-
(2002)
Journal of Hepatology
, vol.36
, Issue.3
, pp. 342-348
-
-
Taïeb, J.1
Delarche, C.2
Paradis, V.3
-
15
-
-
0035383089
-
Hepatocyte growth factor levels in Croatian healthy and alcoholic liver cirrhosis patients
-
N. Antoljak, E. Topić, M. Duvnjak, N. Vrkić, and I. Žuntar, Hepatocyte growth factor levels in Croatian healthy and alcoholic liver cirrhosis patients," Collegium Antropologicum, vol. 25, no. 1, pp. 341-348, 2001.
-
(2001)
Collegium Antropologicum
, vol.25
, Issue.1
, pp. 341-348
-
-
Antoljak, N.1
Topić, E.2
Duvnjak, M.3
Vrkić, N.4
Žuntar, I.5
-
16
-
-
0030470474
-
Human hepatocyte growth factor in alcoholic liver disease: A comparison with change in α-fetoprotein
-
C. L. Mendenhall, F. Roos, T. E. Moritz et al., "Human hepatocyte growth factor in alcoholic liver disease: a comparison with change in α-fetoprotein," Alcoholism: Clinical and Experimental Research, vol. 20, no. 9, pp. 1625-1630, 1996.
-
(1996)
Alcoholism: Clinical and Experimental Research
, vol.20
, Issue.9
, pp. 1625-1630
-
-
Mendenhall, C.L.1
Roos, F.2
Moritz, T.E.3
-
17
-
-
0033753622
-
Hepatocyte growth factor predicts survival and relates to inflammation and intima media thickness in end-stage renal disease
-
L. S. Malatino, F. Mallamaci, F. A. Benedetto et al., "Hepatocyte growth factor predicts survival and relates to inflammation and intima media thickness in end-stage renal disease," American Journal of Kidney Diseases, vol. 36, no. 5, pp. 945-952, 2000.
-
(2000)
American Journal of Kidney Diseases
, vol.36
, Issue.5
, pp. 945-952
-
-
Malatino, L.S.1
Mallamaci, F.2
Benedetto, F.A.3
-
18
-
-
0037979237
-
The impairment of hepatocytes and sinusoidal endothelial cells during cold preservation in rat fatty liver induced by alcohol and the beneficial effect of hepatocyte growth factor
-
Y. Takeda, S. Arii, T. Kaido, and M. Imamura, "The impairment of hepatocytes and sinusoidal endothelial cells during cold preservation in rat fatty liver induced by alcohol and the beneficial effect of hepatocyte growth factor," Transplant International, vol. 16, no. 4, pp. 241-249, 2003.
-
(2003)
Transplant International
, vol.16
, Issue.4
, pp. 241-249
-
-
Takeda, Y.1
Arii, S.2
Kaido, T.3
Imamura, M.4
-
19
-
-
0032919122
-
Increased level of serum hepatocyte growth factor/scatter factor in liver cancer is associated with tumor metastasis
-
H. Junbo, Q. Li, W. Zaide, and H. Yunde, "Increased level of serum hepatocyte growth factor/scatter factor in liver cancer is associated with tumor metastasis," In Vivo, vol. 13, no. 2, pp. 177-180, 1999.
-
(1999)
In Vivo
, vol.13
, Issue.2
, pp. 177-180
-
-
Junbo, H.1
Li, Q.2
Zaide, W.3
Yunde, H.4
-
20
-
-
0028244643
-
IL-6 induces hepatic inflammation and collagen synthesis in vivo
-
I. Choi, H.-S. Kang, Y. Yang, and K.-H. Pyun, "IL-6 induces hepatic inflammation and collagen synthesis in vivo," Clinical and Experimental Immunology, vol. 95, no. 3, pp. 530-535, 1994.
-
(1994)
Clinical and Experimental Immunology
, vol.95
, Issue.3
, pp. 530-535
-
-
Choi, I.1
Kang, H.-S.2
Yang, Y.3
Pyun, K.-H.4
-
21
-
-
0024312875
-
High interleukin-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokines production
-
J. Deviere, J. Content, C. Denys et al., "High interleukin-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokines production," Clinical and Experimental Immunology, vol. 77, no. 2, pp. 221-225, 1989.
-
(1989)
Clinical and Experimental Immunology
, vol.77
, Issue.2
, pp. 221-225
-
-
Deviere, J.1
Content, J.2
Denys, C.3
-
22
-
-
0032985306
-
Mitosis and apoptosis in the liver of interleukin-6-deficient mice after partial hepatectomy
-
T. Sakamoto, Z. Liu, N. Murase et al., "Mitosis and apoptosis in the liver of interleukin-6-deficient mice after partial hepatectomy," Hepatology, vol. 29, no. 2, pp. 403-411, 1999.
-
(1999)
Hepatology
, vol.29
, Issue.2
, pp. 403-411
-
-
Sakamoto, T.1
Liu, Z.2
Murase, N.3
-
23
-
-
78651093454
-
Impaired hepatic removal of interleukin-6 in patients with liver cirrhosis
-
R. Wiest, J. Weigert, J. Wanninger et al., "Impaired hepatic removal of interleukin-6 in patients with liver cirrhosis," Cytokine, vol. 53, no. 2, pp. 178-183, 2011.
-
(2011)
Cytokine
, vol.53
, Issue.2
, pp. 178-183
-
-
Wiest, R.1
Weigert, J.2
Wanninger, J.3
-
24
-
-
0026691627
-
Serum levels of cytokines in chronic liver diseases
-
H. Tilg, A. Wilmer, W. Vogel et al., "Serum levels of cytokines in chronic liver diseases," Gastroenterology, vol. 103, no. 1, pp. 264-274, 1992.
-
(1992)
Gastroenterology
, vol.103
, Issue.1
, pp. 264-274
-
-
Tilg, H.1
Wilmer, A.2
Vogel, W.3
-
25
-
-
0027159404
-
Tumor necrosis factor, interleukin-1 and interleukin-6 in alcoholic cirrhosis
-
A. Diez Ruiz, J. L. Santos Perez, G. Lopez Martinez et al., "Tumor necrosis factor, interleukin-1 and interleukin-6 in alcoholic cirrhosis," Alcohol and Alcoholism, vol. 28, no. 3, pp. 319-323, 1993.
-
(1993)
Alcohol and Alcoholism
, vol.28
, Issue.3
, pp. 319-323
-
-
Diez Ruiz, A.1
Santos Perez, J.L.2
Lopez Martinez, G.3
|